You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 11, 2025

Drug Price Trends for QUININE SULFATE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for QUININE SULFATE

Average Pharmacy Cost for QUININE SULFATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
QUININE SULFATE 324 MG CAPSULE 00093-3002-56 0.64822 EACH 2025-01-22
QUININE SULFATE 324 MG CAPSULE 53489-0700-07 0.64822 EACH 2025-01-22
QUININE SULFATE 324 MG CAPSULE 50742-0238-30 0.64822 EACH 2025-01-22
QUININE SULFATE 324 MG CAPSULE 68180-0560-06 0.64822 EACH 2025-01-22
QUININE SULFATE 324 MG CAPSULE 68180-0560-06 0.70234 EACH 2024-12-18
QUININE SULFATE 324 MG CAPSULE 00093-3002-56 0.70234 EACH 2024-12-18
QUININE SULFATE 324 MG CAPSULE 53489-0700-07 0.70234 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Quinine Sulfate

Market Overview

Quinine sulfate, a naturally sourced alkaloid medication derived from the bark of the cinchona tree, has been a cornerstone in the treatment of malaria and other medical conditions for centuries. The market for quinine sulfate has experienced significant growth in recent years, driven by several key factors.

Current Market Size and Growth

As of 2023, the global quinine sulfate market was valued at $2.23 billion and is projected to grow to $2.41 billion in 2024, representing an 8.3% compound annual growth rate (CAGR)[1][5].

Forecasted Growth

The market is anticipated to continue its robust growth trajectory, reaching $3.33 billion by 2028 at a CAGR of 8.4% from 2024 to 2028. This growth is driven by an increased focus on treating tropical diseases, rising healthcare expenditures in developing nations, growing demand for muscle relaxant medications, and an expanding population in malaria-endemic areas[1][5].

Regional Insights

The Asia-Pacific region has been the largest market for quinine sulfate, followed by other regions such as North America, Europe, South America, the Middle East, and Africa. The dominance of Asia-Pacific is attributed to the high prevalence of malaria and other tropical diseases in this region[1][3].

Market Segmentation

The quinine sulfate market is segmented based on products, applications, and geography.

Products

  • Quinine sulfate tablets
  • Quinine sulfate capsules
  • Quinine sulfate injections
  • Quinine sulfate powder
  • Quinine sulfate oral solutions[2]

Applications

  • Malaria treatment
  • Pharmaceutical industry
  • Tropical medicine
  • Healthcare[2]

Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa[1][3]

Drivers of Growth

Several factors are driving the growth of the quinine sulfate market:

Rising Malaria Cases

The ongoing prevalence of malaria, particularly in sub-Saharan Africa and Southeast Asia, continues to drive the demand for efficient anti-malarial therapies like quinine sulfate[2].

Increased Healthcare Spending

Rising healthcare expenditures in developing countries and favorable government policies and healthcare programs are contributing to market growth[1][2].

Advancements in Pharmaceutical Research

Developments in pharmaceutical research and development are improving the effectiveness and safety of quinine sulfate, enhancing its popularity and market demand[2].

Growing Demand for Natural Products

The increasing consumer interest in natural and organic products is also stimulating growth in the quinine sulfate market, as it offers a plant-based alternative derived from cinchona bark[5].

Market Trends

Generic Anti-Malarial Drugs

There is a rising demand for generic anti-malarial drugs, which is expected to influence the market positively[5].

Technological Integration

Technological advancements in pharmaceutical production are enhancing the efficiency and quality of quinine sulfate production[5].

Regulatory Emphasis on Drug Safety

Heightened regulatory emphasis on drug safety is ensuring that quinine sulfate meets stringent quality standards, further boosting its market credibility[5].

Global Commitment to Malaria Eradication

The broader global commitment to malaria eradication strategies is driving increased investment in healthcare within emerging markets and boosting the demand for quinine sulfate[5].

Key Players

The market is dominated by several key players, including:

  • Sanofi
  • GSK
  • Mylan
  • Novartis
  • Teva Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma
  • AbbVie
  • Sun Pharma
  • Cipla[2]

Challenges and Opportunities

Challenges

Despite the growth, the market faces challenges such as the potential side effects of quinine sulfate and the need for continuous research to improve its safety profile[4].

Opportunities

The market presents several opportunities, including the growing demand for tonic water, which contains quinine, and the potential use of quinine sulfate in treating other medical conditions beyond malaria[3][4].

Price Projections

Given the robust growth rate, the prices of quinine sulfate are expected to remain stable or see a moderate increase. The market's expansion is driven more by volume growth rather than price increases, as the demand for anti-malarial medications continues to rise.

"US sales of certified organic products approached $70 billion in 2023, with dollar sales reaching $69.7 billion, marking a 3.4 percent increase from 2022"[5].

This trend indicates that while prices may adjust to reflect increased demand and production costs, the overall market value is expected to grow significantly.

Key Takeaways

  • The global quinine sulfate market is projected to grow from $2.23 billion in 2023 to $3.33 billion by 2028.
  • The Asia-Pacific region dominates the market due to the high prevalence of malaria.
  • Key drivers include rising malaria cases, increased healthcare spending, and advancements in pharmaceutical research.
  • The market is segmented by products, applications, and geography.
  • Key players include major pharmaceutical companies like Sanofi, GSK, and Novartis.
  • The market faces challenges but presents significant opportunities for growth.

FAQs

What is the current market size of the quinine sulfate market?

The global quinine sulfate market was valued at $2.23 billion in 2023[1].

What is the projected growth rate of the quinine sulfate market?

The market is expected to grow at a CAGR of 8.4% from 2024 to 2028[1].

Which region dominates the quinine sulfate market?

The Asia-Pacific region is the largest market for quinine sulfate[1][3].

What are the main drivers of the quinine sulfate market growth?

Key drivers include rising malaria cases, increased healthcare spending, advancements in pharmaceutical research, and growing demand for natural products[1][2][5].

Who are the key players in the quinine sulfate market?

Key players include Sanofi, GSK, Mylan, Novartis, and other major pharmaceutical companies[2].

Cited Sources

  1. The Business Research Company, "Comprehensive Study On The Global Quinine Sulfate Market: Trends And Market Opportunities 2024-2033"[1].
  2. Market Research Intellect, "Quinine Sulphate Market Size and Projections"[2].
  3. Verified Market Research, "Quinine Sulphate Market Size, Share, Opportunities & Forecast"[3].
  4. Custom Market Insights, "Quinine Market Size, Trends, Share, Global Forecast To 2030"[4].
  5. GII Research, "Quinine Sulfate Global Market Report 2024"[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.